摘要
目的探讨单病种质量控制在急性脑梗死应用中的作用。方法选择2011年9月～2013年8月实行单病种质量控制后的急性脑梗死患者76例（质控后组）,另选2008年9月～2010年8月尚未实行单病种质量控制的急性脑梗死患者67例（质控前组）,对2组48h内抗栓治疗、调脂治疗、康复实施、住院总费用、药费占比、住院日和神经功能缺损评分等7个方面进行比较。结果质控后组调脂治疗比例较质控前组明显升高（90.8%vs 52.2%,P〈0.01）,住院总费用[（16659.90±9775.62）元vs（19957.17±8712.93）元]、药费占比[（48.94±10.46）%vs（52.45±9.85%）]、住院日[（14.49±7.76）d vs（17.16±8.23）d]较质控前组明显降低（P〈0.05）。2组抗栓治疗、康复实施比例和神经功能缺损比较,差异无统计学意义（P〉0.05）。结论实行单病种质量控制能有效降低住院费和药费占比,缩短住院日,提高医师对急性脑梗死调脂治疗的重视,值得在临床推广应用。
Objective To study the application of quality control of single disease in acute ischemic stroke（AIS）patients.Methods Seventy-six AIS patients who underwent quality control of single disease served as a post-quality control group and 67 AIS patients who did not underwent quality control of single disease served as a pre-quality control group.Their antithrombotic therapy within 48 h,lipid-regulating therapy,rehabilitation therapy,hospital cost,medication ratio,hospital stay days and neurological defect score were compared.Results The lipid-regulating therapy ratio was significantly higher while the total hospital cost and medication ratio were significantly lower and the hospital stay days were significantly less in post-quality control group than in pre-quality control group（90.8%vs 52.2%,P〈0.01;16659.90±9775.62 RMB yuan vs 19957.17±8712.93 RMB yuan,48.94%±10.46%vs 52.45%±9.85%,14.49±7.76 days vs 17.16±8.23 days,P〈0.05）.No significant difference was found in antithrombotic therapy within 48 h,rehabilitation therapy and neurological defect score between the two groups（P〉0.05）.Conclusion Quality control of single disease can effectively reduce the hospital cost,medication ratio and hospital stay time of AIS patients,and is thus worthy of popularization in clinical practice.
出处
《中华老年心脑血管病杂志》
CAS
2015年第6期625-627,共3页
Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词
脑梗死
降血脂药
纤维蛋白溶解药
质量控制
康复
brain infarction
antilipemic agents
fibrinolytic agents
quality control
rehabilitation
